Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
72 studies found for:    Open Studies | "Eye Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Eye Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting MRI in Diagnosing Solid Tumors of the Eye and Orbit
Condition: Eye Cancer
Intervention: Procedure: dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
2 Recruiting Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid
Condition: Eye Cancer
Interventions: Procedure: Lymphatic Mapping;   Procedure: SLN Mapping/Biopsy
3 Not yet recruiting Lenvatinib and Capecitabine in Patients With Advanced Malignancies
Conditions: Advanced Cancer;   Malignant Neoplasm of Breast;   Malignant Neoplasms of Bone and Articular Cartilage;   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites;   Malignant Neoplasms of Independent (Primary) Multiple Sites;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs;   Malignant Neoplasms of Thyroid and Other Endocrine Glands;   Malignant Neoplasms of Urinary Tract
Interventions: Drug: Lenvatinib;   Drug: Capecitabine
4 Recruiting The Role of Inflammation in Ocular Tumours
Condition: Ocular Melanoma
Intervention: Other: cSLO imaging
5 Recruiting Postoperative Pain in Orbital Disease and Ocular Tumor
Condition: Postoperative Pain
Intervention: Procedure: general anesthesia,orbital operation
6 Not yet recruiting Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma
Conditions: Malignant Neoplasms, Eye;   Glioblastoma;   Malignant Neoplasms, Brain;   Malignant Neoplasms, Central Nervous System
Interventions: Drug: FDG;   Procedure: PET/CT;   Procedure: MRI
7 Not yet recruiting Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Conditions: Uveal Melanoma;   Hepatic Metastases
Interventions: Device: SIR-Spheres® Yttrium 90;   Drug: ipilimumab;   Drug: nivolumab
8 Recruiting Phase II Evaluating Endoresection of the Tumor Scar or Transpupillary Thermotherapy When Endoresection is Not Feasible After Proton Beam Therapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
Conditions: Uveal Melanoma;   Melanoma, Uveal
Interventions: Procedure: Endoresection;   Procedure: Laser diode
9 Recruiting Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)
Condition: Retinoblastoma
Interventions: Other: Observation;   Drug: Etoposide;   Drug: Vincristine;   Radiation: Orbital irradiation;   Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Thiotepa;   Procedure: Cytapheresis;   Procedure: Peripheral bood stem cell transplantation
10 Recruiting Conservative Treatments of Retinoblastoma
Conditions: Retinoblastoma;   Children;   Retinal Neoplasm
Interventions: Drug: VP16, carboplatin;   Drug: Melphalan;   Drug: VP16, carboplatin, vincristin;   Drug: Carboplatin + laser day 1 (chemothermotherapy);   Device: Laser (local treatment);   Device: cryoapplication (local treatment);   Radiation: I125 radioactive plaques (local treatment);   Drug: intravitreal Melphalan (local treatment)
11 Recruiting Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
Condition: Uveal Melanoma
Intervention: Biological: Blood sampling
12 Recruiting Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
Conditions: Neuroblastoma;   Sarcoma;   Carcinoma;   Desmoplastic Small Round Cell Tumor;   Retinoblastoma;   Wilms Tumor;   Melanoma
Intervention:
13 Recruiting Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: Adjuvant chemotherapy by Fotemustin;   Other: Intensive surveillance
14 Recruiting Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
Condition: Retinoblastoma
Interventions: Drug: Carboplatin;   Drug: Maxitrol®;   Procedure: Focal Therapy;   Procedure: Plaque Radiotherapy
15 Recruiting Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Conditions: Uveal Melanoma;   Choroid Neoplasm
Intervention: Biological: ICON-1
16 Not yet recruiting Intermittent Selumetinib for Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: Selumetinib
17 Not yet recruiting Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye
Condition: Metastatic Uveal Melanoma
Interventions: Drug: Pembrolizumab;   Drug: Entinostat
18 Not yet recruiting Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
Conditions: Amblyopia;   Myopia;   Hyperopia;   Astigmatism;   Cataract;   Retinoblastoma;   Trachoma;   Xerophthalmia;   Glaucoma;   Retinopathy of Prematurity
Interventions: Device: Spot photoscreener;   Procedure: Ophthalmologic evaluation;   Procedure: Cyclopleged refraction
19 Recruiting Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: ipilimumab;   Drug: Nivolumab
20 Recruiting PCI Imaging System in Pediatric Ophthalmology
Condition: Retinoblastoma
Interventions: Procedure: Examination under anaesthetic (EUA);   Device: RetCam;   Device: COSMOS

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years